The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease

Ola Bratta Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden;b Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Göteborg, SwedenCorrespondence[email protected]

https://orcid.org/0000-0002-9198-9445

Stefan Carlssonc Section of Urology, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Per Franssond Department of Nursing, Umeå University, Umeå, Sweden

Jon Kindblome Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden

Johan Strannea Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden;b Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Göteborg, Sweden

https://orcid.org/0000-0002-4295-6524

Camilla Thellenberg Karlssonf Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden

& on behalf of the Swedish National Prostate Cancer Guidelines Group show all

The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date